Sai Pharma Co. Ltd.
(+66) 890000031
Facebook Linkedin

About

About Sai Pharma

To save people, we work
Established in 2006, Sai Pharma mainly imports raw materials (APIs) and finished products/formulations from different countries and distributes them domestically. These pharmaceuticals are majorly sold to the Government Pharmaceutical Organisation (GPO) and other private entities. Our biggest suppliers are Mylan/Viatris, Lupin & Divi’s Labs. The company provides technical marketing support to the customers and acts as a bridge between them and the foreign suppliers, guaranteeing efficient distribution of the products. Maintaining healthy relationships with the customers, fulfilling their needs and ensuring good business practices are the topmost priorities of the business. In the near future, the company is looking to expand its portfolio of pharmaceuticals as well as develop a larger customer base.

Mission

We Import and Distribute Quality Active Pharmaceutical Ingredients & Finished Dosage Formulations of key products needed for treatment of Acute and Chronic ailments of Thai Population

Vision

To act as a valued bridge between Global Biotech & Pharmaceutical Companies AND the Pharmaceutical Fraternity of Thailand to serve the Thai Population with the Best Treatments available in the World

Basic Activities

Importation and Distribution of APIs & Formulations in Thailand.

Specialization

Anti- Retroviral, Hepatology, anti-TB, Oncology, Allergy, CVS & CNS

Age

A modern 15 years old company

Strategy

With Strategic Stake in Local Distribution & Marketing companies, we have reach to each and every member of the Medical Fraternity of Thailand

The Major Suppliers

Mylan Inc., Divi’s Laboratories Limited,  Lupin Limited, IPCA Laboratories Ltd., Aurore Pharmaceuticals,  Micro Labs & Naprod Lifesciences, Dynamic Medicare etc.

Customers in Thailand:

Government Pharmaceutical Organization (GPO), Berlin Pharma, Siam Pharma, Pinnacle Chemmed,  etc.

Our Clients in Thailand

Government Pharmaceutical Organization (GPO), Berlin Pharma, Siam Pharma, Pinnacle Chemmed, etc.

Values

file_type_nsri-integrity

Integrity

Integrity, we deliver what we commit

Quality

Quality, we do not deviate an inch from the best

Communication

Communication, Crystal Clear

Expertise

Expertise, or we drop

Research

Research, evaluate all dimensions

Locate Right Principals who have high quality value added Products – APIs and FDFs

Strategic Investments in Local Marketing & Distribution companies

Register & Import value added Products and promote them through sister concern and Marketing companies

Locations

Sourcing Office in Delhi: five dedicated officials managing the business

Associates in the UK for sourcing Dossiers, technology and products.

Global reach through partners in various continents of the world

Key Officials

Mr. Thevan Tiwari, Managing Director

  • 28 years of Pharmaceutical Importation and Distribution Experience
  • Academic Qualification: Masters of Science (Chemistry)
  • Expertise: Strategy, Sales & Marketing of Pharmaceutical Products
  • Worked with Lupin Thailand/GP Group (JV with Lupin) for a considerable period of time
    • Built its entire market in Thailand especially GPO
    • Sourcing of Products from outside Thailand and trading locally
    • Cultivated massive accounts like Sandoz etc. in Lupin (Thailand)

Mr. Shivkumar Singh

  • 18 years of Pharmaceutical Business Development
  • Academic Qualification: Masters of International Business
  • Expertise: Sales, Marketing, Strategy

Business Details

Turnover: USD 70 Mn (2021)

Financial & Investment status – we are a cash rich company with investments only into Healthcare (primarily Pharma & consumables)

Operational procedures: we do the registration & importation job, while the marketing aspect is taken care by the marketing companies in which we have strategic investments

We operate in other countries, like Laos, Vietnam, Myanmar through our partners

  • Government Pharmaceutical Organization (GPO) – a government body – mandate from MoPH to supply exclusively to Govt Hospitals when GPO manufactures those Products
  • GPO – only government body to organise Compulsory license (CL) products for MoPH either through importation or local production
  • Sai Pharma has partnered with GPO since its inception and are one of the best organisations to understand and successfully conduct business operations with them from a long time
  • Sai Pharma has supported GPO with “difficult to manufacture” formulations of Lopinavir/Ritonavir, Efavirenz, Tenofovir FDCs etc. and made their CL program a successful one 
  • Stepping into transfer of Oncology Products to GPO
  • Other endeavours in the pipeline are Tech Transfer to Chulabhorn Institute for the Oncology Products

Expertise

Sourcing

Sourcing of Bulk Drugs & Finished Dosage formulations

Technology

  • Technology Transfer of Finished Dosage formulations
    • Small molecules – Anti-retrovirals, Cardiovascular, Central Nervous System, Immunosuppressants
    • Injectables
    • Peptides
    • Biologics – Pre-fill & Cell-lines
    • Building capabilities in the Cannabis space

Marketing

  • Marketing of Finished Products in Thailand

Achievements

  • The Biggest Importer of Indian Pharmaceutical Products in Thailand
  • First & only company to register complete Tenofovir basket in Thailand and pursued to include these in the Essential Drug list
  • Supported GPO with organizing formulations like LPV/r, TDF/FTC/EFV, EFV, DTG etc.
  • Successful Tech Transfer of “difficult to manufacture” formulations to GPO
  • Registration of Hep C products like Sofosbuvir, Sof/Ledi in three months time
  • Registration of Biosimilars like Trastuzumab in nine months time
  • Almost single source supplier for the products like Metformin, Omeprazole pellets, Favipiravir etc.

Our Understanding of Thailand Potential

  • 167 manufacturers – huge bulk drug potential
  • Products going off-patent – potential for the newer products
  • Local companies lack in high end technology – Tech Transfer projects have good potential
  • Increasing Geriatric population hence the rise in demand for chronic therapies
  • Lifestyle diseases are increasing like allergies, depression, CNS, CVS, GI etc.
  • Advancement in Medical Treatments have increased the age of the people, hence they want tools to stay healthy and disease free
  • Thai FDA has become agile especially regarding factors like WHO PQ collaborative process
  • Newer delivery options like Nasal Sprays, MDIs & DPIs with parallel Tech Transfer of these products to GPO
  • A portfolio of “difficult to manufacture products” and “products which are going off-patent” in coming years can be formulated

Copyright 2022 Sai Pharma. All Rights Reserved.

Web Design Bangkok by Relevant Audience